英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Icer查看　Icer　在百度字典中的解释百度英翻中〔查看〕
Icer查看　Icer　在Google字典中的解释Google英翻中〔查看〕
Icer查看　Icer　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ICER | Working Towards Fair Pricing, Fair Access, Future Innovation
    ICER, in collaboration with researchers from Brown University, published a new white paper that provides clear policy and market solutions to help manage affordable and equitable access to GLP-1 obesity medications
  • Explore Our Research | ICER
    ICER formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices
  • About Us | Institute for Clinical Economic Review - ICER
    The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests
  • Assessments | Explore Our Research - ICER
    CONTACT US +1 (617) 528-4013 Email: info@icer org Media Inquiries: mediainquiries@icer org © ICER, 2025 Terms and Conditions Privacy Policy Accessibility Statement Linkedin
  • FAQs | What is ICER? | ICER
    ICER seeks to provide an independent source of evidence review—free from financial conflicts of interest—to help patients today and in the future by catalyzing a movement toward fair pricing, fair access, and future innovation across the entire US health care system
  • What is ICER | Institute for Clinical Economic Review
    ICER’s goal is to bring more transparency to that conversation by 1) using evidence to determine the clinical benefit of health interventions, and 2) ensuring all parties can discuss access and pricing concerns in a public setting
  • Cost-Effectiveness, the QALY, and the evLY Gained - ICER
    As researchers that understand the appropriate and ethical use of cost-effectiveness, ICER has drafted a blueprint for policymakers seeking solutions on how to ensure proper use of the QALY in legislation:
  • Press Releases | News Insights - ICER
    Subscribers can expect to receive press releases at the following milestones: Topic Announcement, Draft Evidence Report, Revised Evidence Report, and Final Evidence Report You can also find the week’s press releases in our newsletter For any questions, please contact mediainquiries@icer org
  • Value Assessment Framework - ICER
    ICER’s modified framework for ultra-rare conditions is the culmination of a nine-month public process of engagement with the rare disease patient community, the life sciences industry, and US health care payers
  • Methods Process | Our Approach - ICER
    ICER is driven by a mission to conduct evidence-based reviews of health care interventions, such as drug, devices and diagnostics, that help patients, doctors, and everyone else in the health care system know what works





中文字典-英文字典  2005-2009